Targeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients

dc.contributor.author	Abu Eid, Rasha
dc.contributor.author	Ward, Frank James
dc.contributor.institution	University of Aberdeen.Dental Education	en
dc.contributor.institution	University of Aberdeen.Institute of Medical Sciences	en
dc.contributor.institution	University of Aberdeen.Medical Sciences	en
dc.date.accessioned	2022-09-22T23:17:11Z
dc.date.available	2022-09-22T23:17:11Z
dc.date.embargoedUntil	2022-09-23
dc.date.issued	2021-12
dc.description	Funding This work was supported by Friends of ANCHOR pilot research award [grant number RS 2019 004, 2020-2021]	en
dc.description.status	Peer reviewed	en
dc.format.extent	8
dc.format.extent	652868
dc.identifier	200423798
dc.identifier	bf2b5a0c-bd26-45d8-b22f-7ca66aff1daf
dc.identifier	85115975872
dc.identifier.citation	Abu Eid, R & Ward, F J 2021, 'Targeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients  ', Immunology Letters, vol. 240, pp. 1-8. https://doi.org/10.1016/j.imlet.2021.09.005	en
dc.identifier.doi	10.1016/j.imlet.2021.09.005
dc.identifier.issn	0165-2478
dc.identifier.uri	https://hdl.handle.net/2164/19216
dc.identifier.vol	240	en
dc.language.iso	eng
dc.relation.ispartof	Immunology Letters	en
dc.subject	COVID-19	en
dc.subject	PI3K	en
dc.subject	Akt	en
dc.subject	mTOR	en
dc.subject	Immune modulation	en
dc.subject	Thrombosis	en
dc.subject	RK Dentistry	en
dc.subject	Other	en
dc.subject	RS 2019 004	en
dc.subject	2020-2021	en
dc.subject.lcc	RK	en
dc.title	Targeting the PI3K/Akt/mTOR pathway : A therapeutic strategy in COVID-19 patients	en
dc.type	Journal item	en

Files

Now showing 1 - 1 of 1